Weifeng Shen

4.1k total citations · 1 hit paper
109 papers, 2.9k citations indexed

About

Weifeng Shen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Weifeng Shen has authored 109 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cardiology and Cardiovascular Medicine, 31 papers in Surgery and 30 papers in Molecular Biology. Recurrent topics in Weifeng Shen's work include Coronary Interventions and Diagnostics (11 papers), Cardiac Imaging and Diagnostics (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Weifeng Shen is often cited by papers focused on Coronary Interventions and Diagnostics (11 papers), Cardiac Imaging and Diagnostics (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Weifeng Shen collaborates with scholars based in China, Japan and United States. Weifeng Shen's co-authors include Xiaoxiang Yan, Lin Lu, Chengjun Sui, Ruiyan Zhang, Motoaki Sano, Keiichi Fukuda, Qiujing Chen, Jin Endo, Kentaro Ito and Atsushi Anzai and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Weifeng Shen

101 papers receiving 2.9k citations

Hit Papers

Temporal dynamics of cardiac immune cell accumulation fol... 2013 2026 2017 2021 2013 100 200 300 400

Peers

Weifeng Shen
Weifeng Shen
Citations per year, relative to Weifeng Shen Weifeng Shen (= 1×) peers Florian Blaschke

Countries citing papers authored by Weifeng Shen

Since Specialization
Citations

This map shows the geographic impact of Weifeng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Shen more than expected).

Fields of papers citing papers by Weifeng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Shen. The network helps show where Weifeng Shen may publish in the future.

Co-authorship network of co-authors of Weifeng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Shen. A scholar is included among the top collaborators of Weifeng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Shen. Weifeng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madonna, Rosalinda, Serena Barachini, Sandra Ghelardoni, et al.. (2024). Vasostatins: new molecular targets for atherosclerosis, post-ischaemic angiogenesis, and arteriogenesis. Cardiovascular Research. 120(2). 132–139. 4 indexed citations
3.
Wang, Wei, et al.. (2023). Patterns of Drug Resistance and Bacterial Pathogen Distribution in Patients with Urinary Tract Infections in the Jiaxing Region from 2020 to 2022. Infection and Drug Resistance. Volume 16. 5911–5921. 6 indexed citations
4.
Chen, Qiujing, Lin Lu, Qi Jin, et al.. (2022). Association of Circulating IgE and CML Levels with In-Stent Restenosis in Type 2 Diabetic Patients with Stable Coronary Artery Disease. Journal of Cardiovascular Development and Disease. 9(5). 157–157. 1 indexed citations
5.
Chen, Shuai, Feifei Li, Zhiming Wu, et al.. (2022). High serum levels of N-epsilon-carboxymethyllysine are associated with poor coronary collateralization in type 2 diabetic patients with chronic total occlusion of coronary artery. BMC Cardiovascular Disorders. 22(1). 282–282. 3 indexed citations
6.
Shen, Weifeng. (2021). Dynamically adjusted strategy in response to developments in the COVID-19 pandemic as a new normal. Globalization and Health. 17(1). 89–89. 10 indexed citations
8.
Shen, Weifeng, Libing Jiang, & Xiaojun He. (2020). Precision Augmentation of Medical Surge Capacity for Disaster Response. Emergency Medicine International. 2020. 1–6. 4 indexed citations
9.
Li, Xiaofeng, Cheng Chen, Daimin Xiang, et al.. (2017). Chronic inflammation‐elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance. Hepatology. 66(6). 1934–1951. 104 indexed citations
10.
Ding, Fenghua, Qi Zhang, Zhenkun Yang, et al.. (2016). Predictive value of SYNTAX score II for clinical outcomes in octogenarian undergoing percutaneous coronary intervention.. PubMed Central. 13(9). 733–739. 15 indexed citations
11.
Shen, Ying, Lin Lu, Qi Zhang, et al.. (2015). Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients. Chinese Medical Journal. 128(6). 727–732. 1 indexed citations
12.
Shen, Ying, Feng Wu, Qi Zhang, et al.. (2014). Clinical relevance of angiographic coronary collaterals during primary coronary intervention for acute ST-elevation myocardial infarction. Chinese Medical Journal. 127(1). 66–71. 8 indexed citations
13.
Shen, Weifeng, Libing Jiang, Guanyu Jiang, et al.. (2014). Development of the science of mass casualty incident management: reflection on the medical response to the Wenchuan earthquake and Hangzhou bus fire. Journal of Zhejiang University SCIENCE B. 15(12). 1072–1080. 5 indexed citations
14.
Chen, Kang, Hao Bai, Yanfeng Liu, et al.. (2014). EphB4 Forward‐Signaling Regulates Cardiac Progenitor Development in Mouse ES Cells. Journal of Cellular Biochemistry. 116(3). 467–475. 10 indexed citations
15.
Yu, Xiaohong, Jun Liu, Hao Zhu, et al.. (2013). Synergistic association of DNA repair relevant gene polymorphisms with the risk of coronary artery disease in northeastern Han Chinese. Thrombosis Research. 133(2). 229–234. 21 indexed citations
16.
Shi, Chuan, Lingjie Wang, Jinping Li, et al.. (2010). Prevalence, clinical characteristics and outcome in patients with chronic heart failure and diabetes. Chinese Medical Journal. 123(6). 646–650. 14 indexed citations
17.
Wang, Wei, Ying Chen, Jiumei Cao, et al.. (2010). Elevation of ADAM10, ADAM17, MMP-2 and MMP-9 expression with media degeneration features CaCl2-induced thoracic aortic aneurysm in a rat model. Experimental and Molecular Pathology. 89(1). 72–81. 28 indexed citations
18.
Zhang, Qi, Lin Lu, Ruiyan Zhang, et al.. (2007). Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine. Cardiovascular Diabetology. 6(1). 16–16. 15 indexed citations
19.
Zhang, Dadong, et al.. (2002). Primary intracoronary stenting in comparison with intravenous rt-PA thrombolysis plus rescue intracoronary intervention in patients with acute myocardial infarction.. PubMed. 115(2). 163–5. 6 indexed citations
20.
Yang, Zhenkun, et al.. (2002). Relationship between pulse pressure and incidence of coronary artery disease in hypertensive patients. 30(6). 325–327. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026